Aresma Partners – Corporate Finance and M&A Advisory Services

“If you don’t stand for something,

you’ll fall for anything”

Because Investment Banking could be different

Instagram’s latest feature is a digital business card for your profile October 15, 2024

Instagram is rolling out a new “profile card” feature that is essentially a digital business card for your profile. The official launch comes a few months after the Meta-owned social network was spotted testing the feature with select creators. The new two-sided profile cards are designed to make it easier for users to share their […]

The New York Times has had it with generative AI companies using its content October 15, 2024

The New York Times sent a cease and desist letter demanding that Jeff Bezos-backed Perplexity stop accessing and using its content in AI summaries and other output. The Wall Street Journal reviewed the document. The letter argues that Perplexity has been “unjustly enriched” by using the publisher’s “expressive, carefully written and researched, and edited journalism […]

Forbion, Tolerance Bio, Antiverse October 15, 2024

(Pays-Bas/VC/Closing) – Forbion lève plus de 2 Mds€ via ses deux nouveaux fonds, Forbion Growth Opportunities III et Forbion Ventures VII, portant ses actifs sous gestion à 5 Mds€. Ces fonds ont dépassé leurs objectifs initiaux avec 1,2 Md€ pour Growth Opportunities III et 890 M€ pour Ventures VII. Cette levée permettra d’accroître le nombre […]

Inventiva, Transgene, Innate Pharma, Acticor October 14, 2024

(Daix/Biotech/MASH) – Inventiva (IVA) sécurise un financement pouvant atteindre 348 M€ pour soutenir sa Phase 3, NATiV3, dans la MASH avec lanifibranor. Cette opération inclut une première tranche immédiate de 94,1 M€, avec la possibilité d’ajouter des montants supplémentaires en fonction de certaines conditions. Les principaux investisseurs sont New Enterprise Associates, BVF Partners LP et […]